For example, in human BC xenografts in humanized mice, blocking the recruitment of naive CD4+ T cells in the tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduced intragranular regulatory T cells and inhibited tumor progression [16]. Here, CD4 is linked to breast cancer.